Agilent Technologies, Inc. (BVMF:A1GI34)
Brazil · Delayed Price · Currency is BRL 410.72
+25.47 (6.61%)
At close: Nov 24, 2025
Agilent Technologies Revenue
In the fiscal year ending October 31, 2025, Agilent Technologies had annual revenue of $6.95B USD with 6.73% growth. Agilent Technologies had revenue of $1.86B in the quarter ending October 31, 2025, with 9.41% growth.
Revenue
$6.95B
Revenue Growth
+6.73%
P/S Ratio
6.00
Revenue / Employee
$386.00K
Employees
18,000
Market Cap
224.05B BRL
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Oct 31, 2025 | 6.95B | 438.00M | 6.73% |
| Oct 31, 2024 | 6.51B | -323.00M | -4.73% |
| Oct 31, 2023 | 6.83B | -15.00M | -0.22% |
| Oct 31, 2022 | 6.85B | 529.00M | 8.37% |
| Oct 31, 2021 | 6.32B | 980.00M | 18.36% |
| Oct 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Oct 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Oct 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Oct 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Oct 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Rede D'Or São Luiz | 54.20B |
| Raia Drogasil | 42.23B |
| Empreendimentos Pague Menos | 14.27B |
| Diagnósticos da América | 12.57B |
| Fleury | 8.07B |
| Hypera | 6.97B |
| Oncoclínicas do Brasil Serviços Médicos | 5.94B |
| Dimed S.A. Distribuidora de Medicamentos | 5.29B |